Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1801796
Max Phase: Preclinical
Molecular Formula: C13H10INO2
Molecular Weight: 339.13
Molecule Type: Small molecule
Associated Items:
ID: ALA1801796
Max Phase: Preclinical
Molecular Formula: C13H10INO2
Molecular Weight: 339.13
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1ccccc1)c1cc(I)ccc1O
Standard InChI: InChI=1S/C13H10INO2/c14-9-6-7-12(16)11(8-9)13(17)15-10-4-2-1-3-5-10/h1-8,16H,(H,15,17)
Standard InChI Key: OGEXIPVUPBXZGK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 339.13 | Molecular Weight (Monoisotopic): 338.9756 | AlogP: 3.25 | #Rotatable Bonds: 2 |
Polar Surface Area: 49.33 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.50 | CX Basic pKa: | CX LogP: 3.69 | CX LogD: 3.44 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.83 | Np Likeness Score: -1.46 |
1. Garner AL, Gloeckner C, Tricoche N, Zakhari JS, Samje M, Cho-Ngwa F, Lustigman S, Janda KD.. (2011) Design, synthesis, and biological activities of closantel analogues: structural promiscuity and its impact on Onchocerca volvulus., 54 (11): [PMID:21534605] [10.1021/jm200364n] |
Source(1):